
1. j gastrointestin liver dis. 2009 mar;18(1):51-6.

high sustained virological response rate combination therapy genotype 1
patients histologically mild hepatitis c.

gheorghe l(1), iacob s, grigorescu m, sporea i, sirli r, damian d, gheorghe c,
iacob r.

author information: 
(1)hepatology department, center gastroenterology hepatology, fundeni
clinical institute, carol davila university medicine pharmacy, bucharest. 
drgheorghe@xnet.ro

background: patients mild hepatitis c significant risk disease
progression medium- long-term follow-up considered for
antiviral therapy.
aim: evaluate rate sustained viral response (svr) predictive
factors svr hcv genotype 1 patients mild hepatitis c (fibrosis stage
f0/f1) treated combination antiviral therapy.
methods: 260 na√Øve patients followed-up 72 weeks three referral
hepatology centers 2004 2006. univariate multivariate logistic
regression analysis conducted.
results: early virological response 88.1% svr 74.2%. the
univariate analysis, svr associated young age (p=0.001), low (< 
= 400,000 iu/ml) baseline viremia (p=0.03) high aminotransferase levels
(p=0.04) associated gender, body mass index, inflammatory
activity, steatosis, ribavirin peginterferon dose changes, premature
cessation therapy. multivariate analysis identified following independent 
predictors svr: age <50 years (p=0.0009), viral load < = 400,000 iu/ml
(p=0.03) aminotransferase level >2 times normal value (p=0.02).
conclusions: genotype 1 hcv patients mild hepatitis high rate svr,
similar genotype non-1. young age, low viremia significant
hepatocytolisis independent predictors svr patients mild
hepatitis.


pmid: 19337634  [indexed medline]

